This firm fixed price purchase order is awarded for whole-genome crispr KO crispr KO gene -gene interaction screening-- catalog # crispr screening to horizon discovery LTD. In the amount of $92,500.00

Ended Purchase Order Awarded Last action

Contract number
75N94020P00676
Awardee
Awarding agency
Obligated
$92,500

Award facts

Opportunity
Contract value 100% obligated
$92,500.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Great Britain, United Kingdom

Award details come from SAM.gov/FPDS.

About this award

The National Institute of Child Health and Human Development awarded a firm fixed-price purchase order to Revvity Discovery Limited for $92,500 on August 21, 2020, for whole-genome CRISPR knockout gene-interaction screening services. Performance occurs in Great Britain, United Kingdom, with an ultimate completion date of January 8, 2021. The order originated from a special notice solicitation posted July 29, 2020, with a due date of August 14, 2020. No set-aside was used.

Quick answers

Who was awarded contract 75N94020P00676?

75N94020P00676 was awarded to Revvity Discovery LIMITED by National Institute of Child Health and Human Development (National Institutes of Health) on August 21, 2020.

How much is contract 75N94020P00676 worth?

The government has obligated $92,500 on 75N94020P00676.

Was contract 75N94020P00676 competed?

The extent of competition for 75N94020P00676 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award